Patents by Inventor Andrew Heath

Andrew Heath has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190200550
    Abstract: A method of making a media usable for instance in hydroponics. The method comprising mixing together three components, granulating the mixture and firing the granules formed, the first component is silica sand, the second component is mica granite sand, and the third component is a glass powder, with the firing taking place at a temperature such that the third component melts during firing.
    Type: Application
    Filed: August 25, 2017
    Publication date: July 4, 2019
    Inventors: Victor Andrew HEATH, Michael John TOFT, Craig John TOFT
  • Patent number: 10293552
    Abstract: A film tube installed and sealed in a hollow composite part acts as an internal vacuum bag that eliminates the need for an internal mandrel to react compaction forces applied by autoclave pressure during curing of the part.
    Type: Grant
    Filed: November 17, 2015
    Date of Patent: May 21, 2019
    Assignee: The Boeing Company
    Inventors: Richard Heath, Andrew Elmer Modin
  • Publication number: 20170230357
    Abstract: A multi-factor authentication method and system is provided such that a push notification during an authentication process is only received if a mobile device and user are authenticated prior to receiving the push notification. Either the mobile device itself or a second device sending the push notification may be programmed to either reject or not forward the authentication request. Additionally, using the method of the present invention, enhanced security is provided by requiring the location of the mobile device and the second device to be approximately in the same geographical location.
    Type: Application
    Filed: February 9, 2017
    Publication date: August 10, 2017
    Inventors: Christopher M. Canfield, Herbert W. Spencer, III, Andrew Heath Spencer, Todd S. Hickerson
  • Publication number: 20140322254
    Abstract: The disclosure relates to an adjuvant polypeptide effective at enhancing the immune response to an antigen crosslinked to the adjuvant polypeptide.
    Type: Application
    Filed: November 30, 2012
    Publication date: October 30, 2014
    Applicant: University of Sheffield
    Inventors: Jon Sayers, Peter Arymiuk, Andrew Heath
  • Publication number: 20130195794
    Abstract: The disclosure relates to a vaccine including at least one adjuvant useful in the prevention and treatment of blood cancers, for example lymphoma, leukaemia or myeloma.
    Type: Application
    Filed: February 25, 2011
    Publication date: August 1, 2013
    Inventors: Andrew Heath, Jennifer Carlring-Wright
  • Patent number: 7996442
    Abstract: A method, system, and computer program product provides the capability to compare data object definitions in a database in a less costly and less time-consuming manner than previous techniques. A method of comparing multiple versions of data item definitions in a database comprises generating a first version of comparison information relating to a plurality of data item definitions in the database by comparing information relating to data item definitions obtained from a first source and information relating to data item definitions obtained from a second source and generating a second version of comparison information relating to a plurality of data item definitions in the database by comparing information relating to data item definitions obtained from a first source and information relating to data item definitions obtained from a second source to the first version of comparison information.
    Type: Grant
    Filed: October 17, 2005
    Date of Patent: August 9, 2011
    Assignee: Oracle International Corporation
    Inventors: Andrew Heath Bodge, Harish Akali, Luming Han, Xiaolan Shen
  • Publication number: 20090117135
    Abstract: We describe a conjugate comprising an antibody and antigen wherein said conjugate has low antibody valency and including methods to prepare said conjugate.
    Type: Application
    Filed: January 7, 2009
    Publication date: May 7, 2009
    Inventors: Andrew Heath, Peter Laing
  • Publication number: 20070053920
    Abstract: The invention relates to a set of novel immunological adjuvants based upon so called “polyladder” proteins of nematode worms. These proteins are typified by repeating units separated by a protease cleavage motif of RX(K/R)R or RXFR where R is ariginine, X is any amino acid, K is lysine and F is phenylalanine. These motifs are preceded by a cysteine residue at around 7, 8 or 9 residues upstream. Polyladder proteins or fragments of polyladder proteins may be used as immunological adjuvants either mixed with, or conjugated to a vaccine antigen, and will strongly enhance the immune response against the antigen. Conjugation may take the form of a genetic fusion between adjuvant and antigen. Antigens may be derived from pathogens, or may be tumour antigens, autoantigens, or antigens of other kinds. Vaccines may be used for prophylaxis or therapy.
    Type: Application
    Filed: January 21, 2004
    Publication date: March 8, 2007
    Inventors: Andrew Heath, Peter Laing
  • Publication number: 20060165690
    Abstract: We describe a conjugate comprising an anti-CD40 or anti-CD28 antibody and antigen wherein said conjugate has low antibody valency and including methods to prepare said conjugate.
    Type: Application
    Filed: December 10, 2003
    Publication date: July 27, 2006
    Inventors: Andrew Heath, Peter Laing
  • Patent number: 5766609
    Abstract: A method to protect a host animal from flea infestation by treating that animal with a composition that includes a compound that reduces protease activity of fleas feeding from the treated animal, thereby reducing flea burden on the animal and in the environment of the animal. The present invention also relates to compositions including flea protease vaccines, anti-flea protease antibodies and/or protease inhibitors. Also included in the present invention are soluble flea midgut preparations, flea protease proteins, nucleic acid molecules encoding such proteins and antibodies that selectively bind to such proteins. The present invention also includes methods to obtain and use such preparations, proteins, nucleic acid molecules, antibodies and protease inhibitors to protect an animal from flea infestation.
    Type: Grant
    Filed: October 18, 1994
    Date of Patent: June 16, 1998
    Assignee: Heska Corporation
    Inventors: Robert B. Grieve, Keith E. Rushlow, Shirley Wu Hunter, Glenn R. Frank, Andrew Heath, Miles Yamanaka, Ann Arfsten, Beverly Dale